• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于测量对呼吸道合胞病毒抗原体液反应的电化学发光血清学检测方法的开发

Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus.

作者信息

Maifeld Sarah V, Ro Bodrey, Mok Hoyin, Chu Marla, Yu Li, Yamagata Ryan, Leonardson Tansy, Chio Vera, Parhy Bandita, Park Samuel, Carlson Marcia, Machhi Shushil, Ulbrandt Nancy, Falsey Ann R, Walsh Edward E, Wang C Kathy, Esser Mark T, Zuo Fengrong

机构信息

Applied Immunology and Microbiology, MedImmune, Mountain View, California, United States of America.

Non-clinical Biostatistics, MedImmune, Gaithersburg, Maryland, United States of America.

出版信息

PLoS One. 2016 Apr 12;11(4):e0153019. doi: 10.1371/journal.pone.0153019. eCollection 2016.

DOI:10.1371/journal.pone.0153019
PMID:27070145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4829208/
Abstract

Sensitive and precise serology assays are needed to measure the humoral response to antigens of respiratory syncytial virus (RSV) following natural infection or vaccination. We developed and evaluated a collection of electrochemiluminescent (ECL) serology assays using four RSV antigens (F, N, Ga and Gb). To assess the merits of ECL technology, the four ECL serology assays were evaluated using a well-characterized "gold standard" panel of acute and convalescent serum samples from fifty-nine RSV-positive and thirty RSV-negative elderly subjects (≥65 years old). The combined results from the four ECL assays demonstrated good concordance to the "gold standard" diagnosis, reaching 95% diagnostic sensitivity and 100% diagnostic specificity. Additionally, a combination of ECL assays provided higher diagnostic sensitivity than a commercially available diagnostic ELISA or cell-based microneutralization assay. In summary, these data demonstrate the advantages of using ECL-based serology assays and highlight their use as a sensitive diagnostic approach to detect recent RSV infection in an elderly population.

摘要

需要灵敏且精确的血清学检测方法来测量自然感染或接种疫苗后对呼吸道合胞病毒(RSV)抗原的体液免疫反应。我们开发并评估了一系列使用四种RSV抗原(F、N、Ga和Gb)的电化学发光(ECL)血清学检测方法。为了评估ECL技术的优点,使用来自59名RSV阳性和30名RSV阴性老年受试者(≥65岁)的一组经过充分表征的急性和恢复期血清样本作为“金标准”,对这四种ECL血清学检测方法进行了评估。四种ECL检测方法的综合结果与“金标准”诊断显示出良好的一致性,诊断敏感性达到95%,诊断特异性达到100%。此外,ECL检测方法的组合比市售诊断ELISA或基于细胞的微量中和试验具有更高的诊断敏感性。总之,这些数据证明了使用基于ECL的血清学检测方法的优势,并突出了它们作为一种灵敏的诊断方法用于检测老年人群近期RSV感染的用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9247/4829208/d87c444b1d23/pone.0153019.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9247/4829208/a492fb4c7151/pone.0153019.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9247/4829208/05c5203a05e1/pone.0153019.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9247/4829208/005b52083d8c/pone.0153019.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9247/4829208/d87c444b1d23/pone.0153019.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9247/4829208/a492fb4c7151/pone.0153019.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9247/4829208/05c5203a05e1/pone.0153019.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9247/4829208/005b52083d8c/pone.0153019.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9247/4829208/d87c444b1d23/pone.0153019.g004.jpg

相似文献

1
Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus.用于测量对呼吸道合胞病毒抗原体液反应的电化学发光血清学检测方法的开发
PLoS One. 2016 Apr 12;11(4):e0153019. doi: 10.1371/journal.pone.0153019. eCollection 2016.
2
Serum antibody response to respiratory syncytial virus F and N proteins in two populations at high risk of infection: children and elderly.血清对呼吸道合胞病毒 F 和 N 蛋白的抗体反应在两个高感染风险人群中:儿童和老年人。
J Virol Methods. 2010 Sep;168(1-2):170-6. doi: 10.1016/j.jviromet.2010.05.011. Epub 2010 May 19.
3
Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients.呼吸道合胞病毒(RSV)感染的成人造血细胞移植(HCT)受者对 RSV 结构蛋白的体液和黏膜抗体反应。
Viruses. 2021 May 26;13(6):991. doi: 10.3390/v13060991.
4
Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.呼吸道合胞病毒(RSV)-A 感染造血细胞移植受者的抗原指纹图谱揭示了黏膜抗 RSV G 抗体在控制人类 RSV 感染中的重要性。
J Infect Dis. 2020 Feb 3;221(4):636-646. doi: 10.1093/infdis/jiz608.
5
Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus.呼吸道合胞病毒引起的成人社区获得性肺炎中中和抗体的作用。
Clin Infect Dis. 2012 Apr;54(7):905-12. doi: 10.1093/cid/cir955. Epub 2012 Jan 11.
6
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies.与呼吸道合胞病毒(RSV)相关住院免疫的关联因素:血清中和抗体最低保护阈值水平的确定
Vaccine. 2003 Jul 28;21(24):3479-82. doi: 10.1016/s0264-410x(03)00355-4.
7
Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.表达呼吸道合胞病毒(RSV)G蛋白和F蛋白的重组牛/人3型副流感病毒(B/HPIV3)可用于实现针对RSV和HPIV3的同步黏膜免疫。
J Virol. 2001 May;75(10):4594-603. doi: 10.1128/JVI.75.10.4594-4603.2001.
8
Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model.评价呼吸道合胞病毒 G 指导的中和抗体反应在人呼吸道上皮细胞模型中的作用。
Virology. 2020 Nov;550:21-26. doi: 10.1016/j.virol.2020.08.006. Epub 2020 Aug 20.
9
Development and Validation of an Enzyme-Linked Immunosorbent Assay-Based Protocol for Evaluation of Respiratory Syncytial Virus Vaccines.基于酶联免疫吸附测定法的呼吸道合胞病毒疫苗评价方案的建立与验证。
Viruses. 2024 Jun 12;16(6):952. doi: 10.3390/v16060952.
10
Age-Specific Profiles of Antibody Responses against Respiratory Syncytial Virus Infection.呼吸道合胞病毒感染的抗体反应的年龄特异性特征。
EBioMedicine. 2017 Feb;16:124-135. doi: 10.1016/j.ebiom.2017.01.014. Epub 2017 Jan 16.

引用本文的文献

1
Youth Who Control HIV on Antiretroviral Therapy Display Unique Plasma Biomarkers and Cellular Transcriptome Profiles Including DNA Repair and RNA Processing.接受抗逆转录病毒治疗后控制HIV的青年表现出独特的血浆生物标志物和细胞转录组特征,包括DNA修复和RNA加工。
Cells. 2025 Feb 15;14(4):285. doi: 10.3390/cells14040285.
2
Maternal-Infant Respiratory Syncytial Virus and Influenza A Virus Antibody Transfer in Preterm and Full-term Infants.早产和足月婴儿中母婴呼吸道合胞病毒和甲型流感病毒抗体的传递
Open Forum Infect Dis. 2024 Dec 30;12(1):ofae723. doi: 10.1093/ofid/ofae723. eCollection 2025 Jan.
3
Development and validation of a respiratory syncytial virus multiplex immunoassay.

本文引用的文献

1
Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh.孟加拉国母婴对中呼吸道合胞病毒的经胎盘抗体转移及其动力学
J Infect Dis. 2014 Nov 15;210(10):1582-9. doi: 10.1093/infdis/jiu316. Epub 2014 Jun 5.
2
Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness.呼吸道合胞病毒和其他呼吸道病毒感染在有中度至重度流感样疾病的老年人中。
J Infect Dis. 2014 Jun 15;209(12):1873-81. doi: 10.1093/infdis/jit839. Epub 2014 Jan 29.
3
Current concepts and progress in RSV vaccine development.
呼吸道合胞病毒多重免疫检测法的建立与验证。
Infection. 2024 Apr;52(2):597-609. doi: 10.1007/s15010-024-02180-6. Epub 2024 Feb 8.
4
Development and comparison of immunologic assays to detect primary RSV infections in infants.发展和比较免疫检测法以检测婴儿中的原发性 RSV 感染。
Front Immunol. 2024 Jan 12;14:1332772. doi: 10.3389/fimmu.2023.1332772. eCollection 2023.
5
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants.尼姆斯韦单抗给药后中和呼吸道合胞病毒抗体的持久性及对婴儿呼吸道合胞病毒感染自然免疫应答的激发。
Nat Med. 2023 May;29(5):1172-1179. doi: 10.1038/s41591-023-02316-5. Epub 2023 Apr 24.
6
Development and Standardization of a High-Throughput Multiplex Immunoassay for the Simultaneous Quantification of Specific Antibodies to Five Respiratory Syncytial Virus Proteins.开发和标准化一种高通量多重免疫测定法,用于同时定量五种呼吸道合胞病毒蛋白的特异性抗体。
mSphere. 2019 Apr 24;4(2):e00236-19. doi: 10.1128/mSphere.00236-19.
7
Antibody and B cell responses to an investigational adjuvanted RSV vaccine for older adults.针对老年人的一种新型 RSV 疫苗的抗体和 B 细胞反应。
Hum Vaccin Immunother. 2019;15(10):2466-2474. doi: 10.1080/21645515.2019.1589282. Epub 2019 Jun 3.
8
Development of Luciferase Immunoprecipitation Systems (LIPS) Assay to Detect IgG Antibodies against Human Respiratory Syncytial Virus G-Glycoprotein.用于检测抗人呼吸道合胞病毒G糖蛋白IgG抗体的荧光素酶免疫沉淀系统(LIPS)分析方法的开发。
Vaccines (Basel). 2019 Feb 1;7(1):16. doi: 10.3390/vaccines7010016.
9
Respiratory syncytial virus-associated illness in adults with advanced chronic obstructive pulmonary disease and/or congestive heart failure.呼吸道合胞病毒相关疾病在患有晚期慢性阻塞性肺疾病和/或充血性心力衰竭的成年人中。
J Med Virol. 2019 Jan;91(1):65-71. doi: 10.1002/jmv.25285. Epub 2018 Sep 24.
10
Generalized ROC methods for immunogenicity data analysis of vaccine phase I studies in a seropositive population.用于血清阳性人群中疫苗I期研究免疫原性数据分析的广义ROC方法。
Hum Vaccin Immunother. 2018;14(11):2692-2700. doi: 10.1080/21645515.2018.1489191. Epub 2018 Jul 12.
呼吸道合胞病毒疫苗研发的当前概念与进展
Expert Rev Vaccines. 2014 Mar;13(3):333-44. doi: 10.1586/14760584.2014.878653. Epub 2014 Jan 9.
4
Development of a luciferase immunoprecipitation system assay to detect IgG antibodies against human respiratory syncytial virus nucleoprotein.用于检测抗人呼吸道合胞病毒核蛋白IgG抗体的荧光素酶免疫沉淀系统检测方法的开发。
Clin Vaccine Immunol. 2014 Mar;21(3):383-90. doi: 10.1128/CVI.00594-13. Epub 2014 Jan 8.
5
Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age.一种减毒活呼吸道合胞病毒疫苗在5至24月龄健康的呼吸道合胞病毒血清阴性儿童中的安全性和免疫原性。
PLoS One. 2013 Oct 29;8(10):e77104. doi: 10.1371/journal.pone.0077104. eCollection 2013.
6
Translational sciences approach to RSV vaccine development.呼吸道合胞病毒疫苗研发的转化科学方法。
Expert Rev Vaccines. 2013 Sep;12(9):1047-60. doi: 10.1586/14760584.2013.824706.
7
Respiratory syncytial virus vaccine development.呼吸道合胞病毒疫苗的研发。
Semin Immunol. 2013 Apr;25(2):160-71. doi: 10.1016/j.smim.2013.04.011. Epub 2013 Jun 15.
8
Strategic priorities for respiratory syncytial virus (RSV) vaccine development.呼吸道合胞病毒(RSV)疫苗开发的战略重点。
Vaccine. 2013 Apr 18;31 Suppl 2(Suppl 2):B209-15. doi: 10.1016/j.vaccine.2012.11.106.
9
Respiratory syncytial virus: current progress in vaccine development.呼吸道合胞病毒:疫苗研发的最新进展。
Viruses. 2013 Feb 5;5(2):577-94. doi: 10.3390/v5020577.
10
Viral shedding and immune responses to respiratory syncytial virus infection in older adults.老年人呼吸道合胞病毒感染的病毒脱落和免疫反应。
J Infect Dis. 2013 May 1;207(9):1424-32. doi: 10.1093/infdis/jit038. Epub 2013 Feb 4.